3,5-Dibromopyridine

Warning

H302 (18.9%): Harmful if swallowed [Warning Acute toxicity, oral]；H312 (15.1%): Harmful in contact with skin [Warning Acute toxicity, dermal]；H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]；H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]；H332 (15.1%): Harmful if inhaled [Warning Acute toxicity, inhalation]；H335 (96.2%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 53 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

3,5-Dibromopyridine: Does not have an individual approval but may be used under an appropriate group standard

Acute Tox. 4 (18.9%)；Acute Tox. 4 (15.1%)；Skin Irrit. 2 (100%)；Eye Irrit. 2 (100%)；Acute Tox. 4 (15.1%)；STOT SE 3 (96.2%)

3,5-Dibromopyridine: Does not have an individual approval but may be used under an appropriate group standard